• 1. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 2. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Anisoles

2-(4-Methoxyphenoxy)ethan-1-amine Hydrochloride (CAS No. 98959-77-4): A Comprehensive Overview

2-(4-Methoxyphenoxy)ethan-1-amine hydrochloride (CAS No. 98959-77-4) is a versatile compound with significant applications in the fields of pharmaceutical research and development. This compound, also known as MPEA hydrochloride, has garnered attention due to its unique chemical structure and potential therapeutic properties. In this article, we will delve into the chemical characteristics, synthesis methods, biological activities, and recent research advancements of this compound.

Chemical Structure and Properties

2-(4-Methoxyphenoxy)ethan-1-amine hydrochloride is a white crystalline solid with a molecular formula of C₁₀H₁₄NO₂·HCl and a molecular weight of 208.68 g/mol. The compound features a methoxyphenyl group attached to an ethylamine moiety, which imparts distinct chemical and physical properties. The presence of the methoxy group enhances the lipophilicity of the molecule, making it more suitable for crossing biological membranes. Additionally, the amine group in its hydrochloride salt form ensures good solubility in aqueous solutions, facilitating its use in various biological assays.

Synthesis Methods

The synthesis of 2-(4-methoxyphenoxy)ethan-1-amine hydrochloride can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 4-methoxyphenol with 2-chloroethylamine hydrochloride in the presence of a base such as potassium carbonate. This reaction proceeds via nucleophilic substitution, yielding the desired product in good yields. Another approach involves the alkylation of 4-methoxyphenol with ethylene oxide followed by reductive amination using ammonia or ammonium chloride. These synthetic strategies provide researchers with flexible options to tailor the production process based on specific requirements.

Biological Activities and Applications

2-(4-Methoxyphenoxy)ethan-1-amine hydrochloride has been extensively studied for its potential biological activities, particularly in the context of central nervous system (CNS) disorders. Recent research has shown that this compound exhibits significant neuroprotective effects by modulating neurotransmitter systems and reducing oxidative stress. For instance, studies have demonstrated that MPEA hydrochloride can enhance dopamine release and protect dopaminergic neurons from oxidative damage, making it a promising candidate for the treatment of Parkinson's disease.

In addition to its neuroprotective properties, MPEA hydrochloride has also been investigated for its antidepressant and anxiolytic effects. Preclinical studies using animal models have indicated that this compound can effectively reduce depressive-like behaviors and anxiety symptoms without causing significant side effects. These findings suggest that MPEA hydrochloride may have therapeutic potential in treating mood disorders such as depression and anxiety.

Clinical Trials and Future Prospects

The promising preclinical results of 2-(4-methoxyphenoxy)ethan-1-amine hydrochloride have paved the way for further clinical investigations. Several Phase I and Phase II clinical trials are currently underway to evaluate the safety and efficacy of this compound in human subjects. Early results from these trials have been encouraging, with no major adverse events reported and significant improvements observed in patient outcomes.

In parallel with clinical trials, ongoing research is focused on optimizing the pharmacokinetic properties of MPEA hydrochloride to enhance its bioavailability and therapeutic index. Advanced drug delivery systems such as nanoparticles and prodrugs are being explored to improve the stability and targeting of this compound within the body.

Conclusion

2-(4-Methoxyphenoxy)ethan-1-amine hydrochloride (CAS No. 98959-77-4) is a promising compound with a wide range of potential applications in pharmaceutical research and development. Its unique chemical structure confers valuable properties that make it suitable for various biological assays and therapeutic interventions. Ongoing research continues to uncover new insights into its mechanisms of action and potential clinical benefits, positioning MPEA hydrochloride as a key player in the development of novel treatments for CNS disorders.

• 1758-46-9(2-Phenoxyethylamine)
• 64464-07-9(2-(2-Methoxyphenoxy)ethylamine Hydrochloride)
• 65006-86-2(2-(3,5-dimethoxyphenoxy)ethan-1-amine)
• 1076198-81-6(5-(2-Aminoethoxy)-3-methoxyphenol)
• 98420-50-9(Phenol, 4-(2-aminoethoxy)-, hydrochloride)
• 17959-64-7(2-phenoxyethan-1-amine hydrochloride)
• 50634-76-9(4-(2-Aminoethoxy)phenol)
• 50800-92-5(2-(4-Methoxyphenoxy)ethylamine)
• 61711-95-3(1-(2-Aminoethoxy)-3,5-dimethoxybenzene Hydrochloride)
• 6487-86-1(2-(3-Methoxyphenoxy)ethanamine)